SELECTBIO Conferences Stem Cells in Drug Discovery & Toxicity Screening 2018
Stem Cells in Drug Discovery & Toxicity Screening 2018
Date: October 4 - 5, 2018
Venue: Coronado Island/San Diego, California USA

Keynote Speakers

Shoji Takeuchi

Shoji Takeuchi
Professor and Director, Collaborative Research Center for Bio/Nano Hybrid Process, Institute of Industrial Science, The University of Tokyo

Norio Nakatsuji

Norio Nakatsuji
Chief Advisor, Stem Cell & Device Laboratory, Inc. (SCAD); Professor Emeritus, Kyoto University

Nancy Allbritton

Nancy Allbritton
Kenan Professor of Chemistry and Biomedical Engineering and Chair of the Joint Department of Biomedical Engineering, University of North Carolina and North Carolina State Univsity

Gary Gintant

Gary Gintant
Senior Research Fellow, Abbvie

Roger Kamm

Roger Kamm
Cecil and Ida Green Distinguished Professor of Biological and Mechanical Engineering, Massachusetts Institute of Technology (MIT)

Mark Bradley

Mark Bradley
Professor, Schools of Chemistry and Medicine, University of Edinburgh

James Hickman

James Hickman
Professor, Nanoscience Technology, Chemistry, Biomolecular Science and Electrical Engineering, University of Central Florida; Chief Scientist, Hesperos

Linda Griffith

Linda Griffith
Professor, Massachusetts Institute of Technology (MIT)

Overview

Select Biosciences Stem Cells in Drug Discovery, and Toxicity Screening 2018 brings together researchers from around the world focusing on the emerging technologies and applications in cellular analysis.

The following conferences are co-Located and concurrent and Delegates can Participate, Mix-and-match presentations and network extensively.

Co-Located, Concurrent Conference Tracks:
  • Organ-on-a-Chip World Congress 2018
  • 3D-Bioprinting 2018
  • Stem Cells in Drug Discovery and Toxicity Screening 2018
  • 3D-Culture & Organoids 2018
Hear from and network with researchers who are currently screening for efficacy and toxicity using iPS cell lines, and those responsible for developing the techniques and technologies. There will also be discussions on industry and regulatory developments that are shaping the future of stem cell usage in drug discovery.

Key Opinion Leaders from around the World are Participating at this Conference allowing Maximal Information Exchange and Unparalleled Networking Opportunities.

Call for Posters

You can also present your research on a poster while attending the meeting. Submit an abstract for consideration now!

Poster Submission Deadline: 24 September 2018

Agenda Topics

  • 3D-Cell Culture Based Models
    • Technologies in 3D-Cell Culture
  • iPSC-derived Cells for Toxicity Testing & Screening
  • Screening Technologies, Instrumentation and Reagents
  • Stem Cells in Drug Discovery and Development
  • Use of Microfluidics Organs-on-Chips for Toxicity Screening

Sponsorship and Exhibition Opportunities

For more details, please contact us.

Confirmed Speakers to date

Ulrich Broeckel, Professor of Pediatrics, Medicine and Physiology - Chief, Section of Genomic Pediatrics, Medical College of Wisconsin
Guohao Dai, Associate Professor, Department of Bioengineering, Northeastern University
Toshihiko Ezashi, Research Associate Professor, The University of Missouri
Robert Halliwell, Professor of Neuroscience and Clinical Pharmacology, University of The Pacific
Kennedy Okeyo, Senior Lecturer, Institute for Frontier Life and Medical Sciences, Kyoto University
Daniele Zink, Principal Research Scientist and Team Leader, Institute of Bioengineering and Nanotechology, Agency for Science Technology and Research (A*STAR)


Corporate Sponsors Media Sponsors Official Journal Partner Networking
Drug Discovery WoMetaTagsrld U-Networks
Choose your language
Japanese
Traditional Chinese
Simplified Chinese
Korean